Lawrence H. Lu

Nephrology
1315 Alhambra Blvd Ste 210
Sacramento, CA 95816

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study.

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study.

Journal: Journal for immunotherapy of cancer
Published: May 02, 2021
Showing 1-1 of 1

Last Updated: 09/26/2026